Human Drugs for Veterinary Use Market Share, Causes, Analysis, Overview and Pipeline Review, H1 2016

Human Drugs For Veterinary Use Market Symptoms,
Treatment, Causes, Overview and Pipeline Review, H1 2016
Summary
GBI Research's latest report, ""Human Drugs For Veterinary Use Current Trends and Future Commercial Prospects
for Crossover Drugs"", discusses global commercial trends and prospects for human medicines applied in the
veterinary setting, also called crossover drugs. A wide range of human drugs continue to be applied in the
veterinary space due to a lack of approved animal therapies, convenience and the rising costs of veterinary
research.
This new report provides insights into Extra-label Drug Use (ELDU), its application in the veterinary setting and
other guidelines and regulations followed by professionals in the animal health industry. Through a series of indepth case studies this report provides insights into the rationale for the transition of several human drugs to the
veterinary setting as well as disease overviews, competing treatments, manufacturer information, dosage forms,
cost of therapy and other insightful marketing information. Our new study also identifies and explores important
drivers and restraints of the crossover drugs market.
Browse Complete Summary, Click Here @ http://www.radiantinsights.com/research/human-drugs-forveterinary-use
Information leveraged from our robust industry-leading database shows a diverse range of marketed human drugs
being used in companion animals especially cats, dogs and horses. Our new report includes detailed profiles of key
animal health companies with diverse portfolios of crossover drugs as well as strategies being employed by
competitors in this market to leverage human therapies into the veterinary space. Additionally, we identify
emerging companies marketing various crossover drugs across a range of therapy areas.
GBI Research conducted extensive research in order to provide a comprehensive view of the current trends and
commercial prospects for crossover drugs. This new report...